The 581-aa "Mitophagy Gate" That Fails in Early-Onset Parkinson: Why Your PINK1 WB Gives a 63/52-kDa Doublet Smudge — And How ABP59917 Clears the Noise
If you've ever run a PINK1 western after FCCP treatment and stared at a fuzzy 52–63 kDa doublet wondering which band corresponds to the active OMM-anchored form and which is the degraded intermembrane space (IMS) fragment, you've already hit the two pain points that make PINK1 one of the most frustrating autophagy markers to validate cleanly. The 581-aa serine/threonine ubiquitin kinase (human UniProt Q9BXM7, mouse Pink1 UniProt Q99MQ5, Gene ID 50974) sits at the top of the PINK1–Parkin mitophagy cascade — the only pathway that selectively clears damaged mitochondria before they dump ROS and cytochrome c into the cytosol — and its loss-of-function mutations are the single most common cause of autosomal recessive early-onset Parkinson's disease (EOPD), accounting for 5–10%…
The "Boar Sweat" Receptor That's Also in Your Fat and Colon: Why OR7D4 Research Needs a Rabbit Polyclonal That Doesn't Cross-React to Sibling ORs — And How ABP59752 Delivers
If you still relegate olfactory receptors (ORs) to the nasal epithelium as "smell-only" 7-transmembrane (7TM) GPCRs that fire when you catch a whiff of coffee, skunk spray, or a ripe peach, you've missed the last decade of non-olfactory OR work that has tethered these ~400-member Class A GPCR cousins to lipid metabolism, sperm maturation, colorectal cancer (CRC) progression, and even brown adipose thermogenesis. The poster child for this off-label OR relevance is OR7D4 — the receptor that dictates whether you can smell androstenone (the steroid in boar sweat that splits ~50% of humans into "foul" and ~50% into "odorless" perceivers) — which also shows reproducible expression in white adipose tissue (WAT), testicular somatic cells, and treatment-resistant CRC tumors. The catch?…
The 160-kDa SR Glycoprotein Your Calcium-Handling Paper Forgot: Why SRL (Sarcalumenin) Needs a 0.078 ng/mL Sandwich — And How KTE70256 Pulls a GTP-Binding Lumen Protein Out of the Longitudinal Reticulum
If you've ever stared at a sarcoplasmic reticulum (SR) biochemistry slide and recited the "big three" — RYR1 (release), SERCA2a (re-uptake), calsequestrin (luminal buffer) — you've already made the mistake that most skeletal/cardiac muscle papers make. Because tucked into the longitudinal SR (LSR) lumen and the non-junctional stretches of the terminal cisternae is a 160-kDa acidic N-glycosylated calcium-binding glycoprotein called Sarcalumenin (SRL, UniProt: Q7TQ48, Gene ID: 106393, Srl) that does two things the textbooks skip: (1) it buffers ~30–40% of the total exchangeable Ca²⁺ inside the SR lumen alongside calsequestrin, and (2) it belongs to the TRAFAK-class dynamin-like GTPase superfamily (yes — GTP-binding, GO:0005525) with annotated roles in endocytosis, store-operated calcium entry (SOCE), and "response to muscle activity involved in…
The 8-kDa Proline-Rich "Cellular Scaffold" Hiding Inside Your Mouse Skin, Esophagus, and Injured Nerve: Why Cornifin-A (SPRR1A) Deserves Its Own Sandwich ELISA — And How KTE70246 Finally Pulls It Out of the Cross-Linked Cornified Envelope
If you work on epithelial barrier, wound healing, or squamous carcinogenesis in mice, you've almost certainly run K14, loricrin, filaggrin, and involucrin on the same Western blot — and then stopped, because "keratinocyte terminal differentiation" felt covered. But there's a quieter family of small proline-rich proteins (SPRRs — Small Proline-Rich Proteins) that does the actual cross-linking scaffolding inside the cornified envelope (CE), and Cornifin-A (SPRR1A, UniProt: P80512, Gene ID: 20743, Sprr1a) is the inducible, repair-associated member that K14 can't see and loricrin won't tell you. A ~72–75 aa, ~7.5–8.5 kDa computed proline-rich peptide (Pro content ~30–40%, plus multiple GGGP/Q repeats that are the substrate handles for transglutaminase 1/3 (TGM1/TGM3) to ε-(γ-glutamyl)lysine-crosslink SPRR1A into the loricrin/involucrin matrix of the CE), SPRR1A…
The 17-kDa Trimer That Peaks Before IL-6 Even Wakes: Why Your LPS Model Lives or Dies on an 8 pg/mL Mouse TNF-α Sandwich — And How KTE7015 Puts the Storm Initiator on a 450 nm Curve
If IL-6 is the furnace and IL-1β is the fire alarm, TNF-α is the spark that lights both — and then vanishes before either of them peaks. Give a mouse 1 mg/kg LPS i.p. and the serum timeline is brutal and precise: TNF-α spikes by 30–60 min, peaks 1–2 h at 5,000–50,000 pg/mL depending on dose/strain, and is 80% gone by 4–6 h — meanwhile IL-1β is just cresting at 2–4 h and IL-6 won't peak until 4–6 h and will stay high through 24 h. Miss the 1-hour bleed and you've missed the molecule that started the cascade. That molecule is TNF-α (Tumor Necrosis Factor alpha, alias TNF, cachectin, gene Tnf, UniProt: P06804, Gene ID: 21926) — a 235-aa type…
The 25-kDa "Jekyll and Hyde" That Sleeps in the Matrix Until αvβ6 Yanks the RGD: Why Your Fibrosis/Treg/EMT Claim Collapses Without the Acid-Activated TGF-β1 Sandwich — And How KTE7014 Catches Both Latent and Active Pools on One 450 nm Plate
If there's one cytokine in the mouse house whose name should come with a methods-level warning label, it's TGF-β1 (Transforming Growth Factor beta-1, gene Tgfb1, UniProt: P04202, Gene ID: 21803). Everyone knows the headline roles — "master of fibrosis," "Treg-differentiating Immunomodulator," "EMT driver," "early tumor suppressor / late prometastatic switch" — but almost nobody treats it like the structurally bifurcated pro-protein it actually is. Unlike TNF-α or IL-6, which secrete as more-or-less ready-to-signal dimers, TGF-β1 is born as a ~390-aa precursor (signal peptide + LAP ("latency-associated peptide," ~250 aa pro-region) + mature homodimer (2 × 112 aa, ~12.5 kDa monomer, ~25 kDa non-reducing disulfide-stabilized dimer)) — and the moment it exits the cell, the LAP stays non-covalently clamped onto the…
The 155-aa "Neutrophil Whistle" That Made Secukinumab a Billion-Dollar Biologic: Why Your "Th17 Was Elevated" Claim Needs a 15 pg/mL IL-17 Sandwich — And How KTE7012 Puts the RORγt Signature on a Plate You Can Batch
If TNF-α is the "first responder" of innate cytokine storms and IL-6 is the furnace that keeps the acute-phase factory running, IL-17A is the one that shows up 24–48 h later wearing a Th17 badge and a neutrophil-recruitment whistle — and somehow still manages to be the cytokine that justified the first post-anti-TNF success story in psoriasis (secukinumab, ixekizumab, brodalumab) with >$5B combined annual revenue. The protein in question is IL-17A (alias CTLA-8, gene Il17a, UniProt: P63382, Gene ID: 16171) — a 155-aa mature secreted peptide, computed 17.5 kDa monomer, but biologically active as a disulfide-stabilized homodimer (35 kDa non-reducing) that binds IL-17RA/IL-17RC heterodimer → Act1 (CIKS) → TRAF6 → canonical NF-κB + MAPK + indirect C/EBP → G-CSF, CXCL1/2, IL-6,…
The "Endothelial Brake" That Also Drives IBD and Checkpoint Resistance: Why Your TL1/TL1A–DR3 Readout Needs a 15 pg/mL Floor — And How KTE70114 Puts the TNFSF15 Ligand on a 96-Well Plate
(Note up front: TL1 is used interchangeably with TL1A (TNF-like ligand 1A) in most literature; both refer to the TNFSF15-encoded ligand. This article uses the kit-matched shorthand TL1 throughout.) If you've scrolled through Crohn's disease GWAS catalogs in the past five years, you've likely noticed a recurring culprit: TNFSF15, the gene encoding Tumor necrosis factor-like ligand 1 (TL1, alias VEGI = vascular endothelial growth inhibitor). What makes this entry in the TNF superfamily so counterintuitive is that it carries none of the classic "storm" baggage of its cousin TNF-α: it doesn't trigger the first-wave pyrogenic spike in sepsis, it doesn't directly drive the caspase-8-dependent apoptosis that made TNF-α a household name in immunology textbooks. Instead, it moonlights as a vascular…
The 178-Aa "Fire Marshal" That Tells Macrophages to Stand Down: Why Your "Anti-Inflammatory" Claim Collapses Without a 50 pg/mL IL-10 Sandwich — And How KTE7010 Catches the Whisper Under the Cytokine Storm
Every immunology paper since 1989 has treated IL-10 as the tidy footnote to the TNF/IL-1β/IL-6 storm trio — the "anti-inflammatory cytokine" you invoke when you need to explain why the swelling went down, the Th1 response didn't overshoot, or the Treg adopted a tolerogenic stance. But that footnote undersells what is actually a master rheostat of immune resolution: Il10 (UniProt: P18893, Gene ID: 16153) encodes a 178-aa mature secreted peptide, ~18.5 kDa monomer, non-reducing ~36–40 kDa disulfide-stabilized homodimer that binds the IL-10R1 (ligand-specific, low-affinity) + IL-10R2 (signal-transducing, shared with IL-22/IFN-λ/TNFSF10) heterotetramer → JAK1/TYK2 → STAT3 (Tyr⁷⁰⁵) → SOCS3 negative feedback — and its entire job description is to walk into the aftermath of a TNF/IL-1β/IL-6 flare and tell NK cells,…
The 212-aa "BSF-2" Storm Engine That Predicts Septic Survival Better Than TNF: Why Your Mouse IL-6 Readout Needs a 3-pg/mL Floor — And How KTE7009 Puts the gp130 Cytokine on a Plate You Can Actually Batch
If TNF-α is the "first responder" of innate cytokine storms, IL-6 is the one that moves in, turns on the liver like a furnace, and refuses to leave until the acute-phase factory is running at full tilt. Originally cloned in the mid-1980s as BSF-2 (B-cell stimulatory factor 2) for its ability to drive plasma-cell differentiation and IgG production, Il6 (UniProt: P08505, Gene ID: 16193) has spent the last thirty years metastasizing across every inflammatory lane in the mouse house — LPS endotoxemia, CAF-rich TMEs, obese epididymal adipose M1 crowns, rheumatoid pannus, bone-resorption coupling, exercise myokines, and even neurological aging where it's made by reactive astrocytes. The protein itself is a 212-aa, ~23–25 kDa secreted glycoprotein (two N-linked glyco sites, runs…
